PARP inhibition in Ewing sarcoma: impact of germline DNA damage repair defects and activation of immunoregulatory pathways
Lisa M. Maurer(University of Pittsburgh), Kelly M. Bailey(University of Pittsburgh)
Cited by 1
Related Papers
Efficacy of FGFR Inhibitors and Combination Therapies for Acquired Resistance in FGFR2-Fusion Cholangiocarcinoma
|Molecular Cancer Therapeutics|2020|138
Ewing Sarcoma and Osteosarcoma Have Distinct Immune Signatures and Intercellular Communication Networks
|Clinical Cancer Research|2022|85